SCHEMBL22428016

SCHEMBL22428016

CC(C)c1cc(-c2ccccc2Cl)n(O)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
FABP3 P05413 4/20 0.39
HSD11B1 P28845 4/20 0.39
LMNA P02545 2/20 0.36
FABP7 O15540 1/20 0.36
FABP5 Q01469 1/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
EGLN2 Q96KS0 1/20 0.36
SNCA P37840 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
ALOX15 P16050 2/20 0.35
NFKB1 P19838 2/20 0.35
NFKB2 Q00653 2/20 0.35
RELA Q04206 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667991 0.82 HSD11B1 (0.43) KMT2AMEN1FABP3HSD11B1LMNA
SCHEMBL12000462 0.78 KMT2A (0.53) KMT2AMEN1FABP3LMNAFABP7
SCHEMBL2609338 0.67 USP7 (0.47) KMT2AHSD11B1NPC1RAB9A
SCHEMBL8486970 0.67 HSD11B1 (0.44) KMT2AMEN1HSD11B1LMNAALDH1A1
SCHEMBL8373877 0.67 HSP90AA1 (0.41) KMT2AMEN1HSD11B1LMNAALDH1A1
SCHEMBL8301498 0.66 P2RX7 (0.45) KMT2AMEN1HSD11B1LMNAALDH1A1
SCHEMBL17788468 0.66 MEN1 (0.47) KMT2AMEN1ALDH1A1SMN1; SMN2NPC1
SCHEMBL2609401 0.66 CYP2A6 (0.42) HSD11B1
SCHEMBL19531799 0.65 KDM5A (0.43) KMT2AHSD11B1LMNAALDH1A1SMN1; SMN2
SCHEMBL680116 0.65 HSD11B1 (0.50) KMT2AMEN1HSD11B1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200288710-A1 SUBSTITUTED SULPHONAMIDES FOR CONTROLLING ANIMAL PESTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200288710-A1 SUBSTITUTED SULPHONAMIDES FOR CONTROLLING ANIMAL PESTS DDT, MPST, STOM KMT2A 392/4885MEN1 1706/4885FABP3 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.